Geo News
Community curated by people like you
LatestAICryptoHealthWorld AffairsUS Politics

Gray market injectables stories

Aug 12, 2026

Eli Lilly escalates legal fight against black market for experimental weight-loss drug retatrutide

Eli Lilly is stepping up legal action against a booming black market for retatrutide, an experimental weight-loss drug the company is counting on to expand its franchise beyond approved medications like Zepbound.

Aug 12, 2026·2 sources
00

Top claims

  • ▪Eli Lilly & Co. is escalating its fight against a growing black market for its experimental weight-loss drug retatrutide as of August 12, 2026
  • ▪Counterfeit versions of Eli Lilly & Co.'s experimental drug retatrutide are being sold online, at wellness clinics, and at medical spas
  • ▪The experimental weight-loss drug retatrutide has not received regulatory approval from any health authority worldwide as of August 12, 2026

Subtopics

Eli Lilly1Pharma1Retatrutide1Weight loss drugs1Zepbound1

Related timelines

Congress

110 stories

Crypto hacks

100 stories

Iran War

209 stories

Payments

118 stories

Russia-Ukraine war

136 stories